ADAM15 to α5β1 integrin switch in colon carcinoma cells: A late event in cancer progression associated with tumor dedifferentiation and poor prognosis

ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma

(2010) Christopher Ungerer et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Role of ADAMs in Cancer Formation and Progression

(2009) M. J. Duffy et al.   CLINICAL CANCER RESEARCH

Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins

(2009) Iivari Kleino et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

ADAM15 Supports Prostate Cancer Metastasis by Modulating Tumor Cell-Endothelial Cell Interaction

(2008) A. J. Najy et al.   CANCER RESEARCH

Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds  5 1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study

(2008) A. D. Ricart et al.   CLINICAL CANCER RESEARCH

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front

(2008) Olivier Wever et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells

(2008) Youwen Yang et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

ADAM-15: a metalloprotease that mediates inflammation

(2007) Laetitia Charrier-Hisamuddin et al.   FASEB JOURNAL

Molecular Classification and Correlates in Colorectal Cancer

(2007) Shuji Ogino et al.   JOURNAL OF MOLECULAR DIAGNOSTICS